Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.90 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.90 |
| ▸ | TSHR | P16473 | 2/20 | 0.79 |
| ▸ | GJA1 | P17302 | 1/20 | 0.79 |
| ▸ | GJB2 | P29033 | 1/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.79 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14922823 | 1.00 | ALOX15 (0.90) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL19917387 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL12535725 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL13018550 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL17265214 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL23879718 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL14944403 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL16174041 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL9250504 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 | |
| Bekanamycin SCHEMBL12553422 | 0.95 | ALOX15 (1.00) | ALOX15KDM4ETSHRGJA1GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10203334-B2 | Methods and compositions related to nucleic acid binding assays | Nubad, LLC (US) | 2019-02-12 | — | — | US | claimed |
| US-20160282357-A1 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS | Nubad, LLC | 2016-09-29 | — | — | US | claimed |
| US-9017943-B2 | Methods and compositions related to nucleic acid binding assays | NUBAD LLC (US) | 2015-04-28 | — | — | US | claimed |
| US-20140330001-A1 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS | Nubad, LLC (US) | 2014-11-06 | — | — | US | claimed |
| WO-2008005276-A2 | GROWTH FACTOR DELIVERY SYSTEM CONTAINING ANTIMICROBIAL AGENTS | DIRECTCONTACT LLC (US) | 2008-01-10 | — | — | WO | claimed |
| WO-2000040692-A9 | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACIDS | VALENTIS INC (US) | 2001-06-07 | — | — | WO | claimed |
| WO-2000040692-A2 | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACIDS | VALENTIS, INC. (US) | 2000-07-13 | — | — | WO | claimed |
| US-5900406-A | Use of antibiotics of the type 2-deoxystreptamine substituted with aminosugars to inhibit growth of microorganisms containing group I introns | NZYM, INC. (US) | 1999-05-04 | — | — | US | claimed |
| CN-1106401-A | Novel macrolides and the use thereof | CIBA GEIGY AG (CH) | 1995-08-09 | — | — | CN | claimed |
| EP-0445563-B1 | Use of an antibacterial and deodorant processing agent | MEIJI SEIKA KAISHA (JP) | 1995-05-24 | — | — | EP | claimed |
| US-5268168-A | Shiff base | SAKAI ENGINEERING CO., LTD. (JP) | 1993-12-07 | — | — | US | claimed |
| US-5229132-A | Simultaneous administration of coated and uncoated drug forms, improved treatment of stomach and intestines | GRIMBERG GEORGES SERGE (FR) | 1993-07-20 | — | — | US | claimed |
| EP-0445563-A2 | Use of an antibacterial and deodorant processing agent | MEIJI SEIKA KAISHA LTD. (JP) | 1991-09-11 | — | — | EP | claimed |
| US-4297485-A | Production of a selectively protected N-acylated derivative of an aminoglycosidic antibiotic | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1981-10-27 | — | — | US | claimed |
| US-4136254-A | PROCESS OF SELECTIVELY BLOCKING AMINO FUNCTIONS IN AMINOGLYCOSIDES USING TRANSITION METAL SALTS AND INTERMEDIATES USED THEREBY | SCHERING CORPORATION (US) | 1979-01-23 | — | — | US | claimed |
| US-4120955-A | BACTERICIDES | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1978-10-17 | — | — | US | claimed |
| US-3965089-A | Process for the production of a cyclic ureido-derivative of a deoxystreptamine-containing antibiotic and products thereof | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JA) | 1976-06-22 | — | — | US | claimed |
| JP-53046940-A | — | — | None | — | — | JP | disclosed |
| US-3965089-A | Process for the production of a cyclic ureido-derivative of a deoxystreptamine-containing antibiotic and products thereof | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JA) | 1976-06-22 | — | — | US | disclosed |
| US-3939043-A | CULTURING STREPTOMYCES HOFUENSIS | ABBOTT LABORATORIES (US) | 1976-02-17 | — | — | US | disclosed |